Welcome to LookChem.com Sign In|Join Free
  • or
AKOS BBS-00000337 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

29171-70-8

Post Buying Request

29171-70-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

29171-70-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 29171-70-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,1,7 and 1 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 29171-70:
(7*2)+(6*9)+(5*1)+(4*7)+(3*1)+(2*7)+(1*0)=118
118 % 10 = 8
So 29171-70-8 is a valid CAS Registry Number.

29171-70-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(Dimethylsulfamoyl)benzoyl chloride

1.2 Other means of identification

Product number -
Other names 4-Dimethylsulfamoyl-benzoyl chloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:29171-70-8 SDS

29171-70-8Relevant academic research and scientific papers

1,2-Dibenzamidobenzene inhibitors of human factor Xa

Herron, David K.,Goodson Jr., Theodore,Wiley, Michael R.,Weir, Leonard C.,Kyle, Jeffrey A.,Yee, Ying K.,Tebbe, Ann Louise,Tinsley, Jennifer M.,Mendel, David,Masters, John J.,Franciskovich, Jeffry B.,Sawyer, J. Scott,Beight, Douglas W.,Ratz, Andrew M.,Milot, Guy,Hall, Steven E.,Klimkowski, Valentine J.,Wikel, James H.,Eastwood, Brian J.,Towner, Richard D.,Gifford-Moore, Donetta S.,Craft, Trelia J.,Smith, Gerald F.

, p. 859 - 872 (2007/10/03)

High-throughput screening of a combinatorial library of diamidophenols yielded lead compounds with the ability to inhibit human factor Xa (fXa) at micromolar concentrations (e.g. compound 4, fXa apparent K(ass) = 0.64 x 106 L/mol). SAR studies in this novel structural series of fXa inhibitors showed that the phenolic hydroxyl group was not essential for activity. The best activity was found in substituted 1,2-dibenzamidobenzenes in which the phenyl group of one benzoyl group (A-ring) was substituted in the 4-position with relatively small lipophilic or polarizable groups such as methoxy, vinyl, or chloro and the phenyl group of the other benzoyl group (B-ring) was substituted in the 4-position with larger lipophilic groups such as tertbutyl or dimethylamino. The central phenyl ring (C-ring) tolerated a wide variety of substituents, but methoxy, methanesulfonamido, hydroxyl, and carboxyl substitution produced slightly higher levels of activity than other substituents when present in combination with favorable B-ring substitution. Methylation of the amide nitrogen atoms was found to greatly decrease activity. Compound 12 is the highest affinity fXa inhibitor in this group of compounds, having fXa apparent K(ass) = 25.5 x 106 L/mol, about 40x more active than the original lead. This lead series does not show potent inhibition of human thrombin. A model for the binding of these ligands to the fXa active site is proposed. The model is consistent with the observed SAR and can serve to guide future SAR studies.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 29171-70-8